Genmab A GMAB
NASDAQ GMAB
$39.81 +0.24 (+0.62%)
As of: Oct 22, 2026 · 10:13 AM EDT

Genmab A (GMAB) Other Non-Current Assets (2025)

Updated

Genmab A (GMAB) recorded Other Non-Current Assets of $24 million in the quarter ended Jun 30, 2026, up 9.1% from the prior quarter.

Analysis

Genmab A (GMAB) Other Non-Current Assets (2025) Analysis & Trends

As of Dec 31, 2025, Genmab A reported Other Non-Current Assets of $22 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn 14.27 Bn
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn 10.73 Bn
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn -
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn 4.75 Bn
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn 9.94 Bn
10 Genmab A 2.58 Bn -2.80 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 14.00 Mn
Sep 30, 2025 9.00 Mn
API Access

Genmab A Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GMAB&period=max&api_key=YOUR_API_KEY